Para citar este trabalho use um dos padrões abaixo:
Chromoblastomycosis is a chronic infection of skin and subcutaneous tissue caused by traumatic implantation of dematiaceous fungi. This disease has been a serious problem for physicians because it does not have a treatment or drug of choice. Considering that, discovery of new antifungals drugs is necessary. Epiisopiloturine is an imidazole alkaloid extracted from Pilocarpus microphyllus, a native plant of North and Northeast regions of Brazil, popularly known as “jaborandi”. Some studies have related antifungal activity of this alkaloids’ class to their action on topoisomerases, which are present inside cells. Reports in literature show that topoisomerase inhibitors associated with antifungals have synergistic action against black fungi.Thus, this study aimed to investigate the antifungal potential of epiisopiloturine, isolated and in combination with amphotericin B, against chromoblastomycosis agents. Twelve strains of chromoblastomycosis agents, which belong to GEAMICOL-UFPI, were evaluated. The antifungal activity was determinated by using the broth microdilution method according to the protocol M38-A2 of CLSI and interaction between epiisopiloturine and amphotecin B was verified through the chessboard method, by the Fractional of Inhibitory Concentration Index (FICI). To compare the effect of morphological changes of amphotericin B and epiisopiloturine, alone or in combination, atomic force microscopy was used to obtain images from Fonsecaea pedrosoi ATCC 46428. The type II topoisomerase structures and its binder were submitted to Achilles Blind Docking, aiming to find the better active site for epiisopiloturine. Amphotericin B showed MIC values of 4 to 8 μg/mL. Epiisopiloturine could not inhibit any of the fungal isolate tested (MIC ≥ 256 μg/mL). However, in association with amphotericin B, epiisopiloturine exhibited synergism in all fungal samples evaluated (FICI = 0,5). The combination of epiisopiloturine with amphotericin B demonstrated hyphal alteration compared to control and isolated treatments, with total destruction and possible cytoplasmic material extravasation. The docking analysis indicated that epiisopiloturine may have some degree of affinity for type II topoisomerase. Our results were similar to other findings in literature as interaction between topoisomerases and antifungal drugs reinforces the hypothesis about epiisopiloturine’s mechanism of action. This synergistic effect is promising against chromoblastomycosis agents and it could be used to treat this disease in the future.
Com ~200 mil publicações revisadas por pesquisadores do mundo todo, o Galoá impulsiona cientistas na descoberta de pesquisas de ponta por meio de nossa plataforma indexada.
Confira nossos produtos e como podemos ajudá-lo a dar mais alcance para sua pesquisa:
Esse proceedings é identificado por um DOI , para usar em citações ou referências bibliográficas. Atenção: este não é um DOI para o jornal e, como tal, não pode ser usado em Lattes para identificar um trabalho específico.
Verifique o link "Como citar" na página do trabalho, para ver como citar corretamente o artigo